OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
30 hedge funds and large institutions have $1.86M invested in OncoSec Medical Incorporated in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 33 → 30 (-3)
30% less capital invested
Capital invested by funds: $2.64M → $1.86M (-$787K)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$313K |
| 2 |
Jane Street
New York
|
+$13.1K |
| 3 |
LPL Financial
San Diego,
California
|
+$7.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.24K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$412K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$295K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$32.8K |
| 4 |
Bank of New York Mellon
New York
|
-$29.1K |
| 5 |
Millennium Management
New York
|
-$26K |
ONCS Hedge Fund Activity: Q1 2019 in Review
30 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2019, worth a combined $1.86M — down 30% from $2.64M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ONCS and 3 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Intrinsic Edge Capital Management, opening a new position worth an estimated $313K. The largest seller was Anson Funds Management, exiting entirely with an estimated $412K sold.
- 30 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2019, down from 33 in Q4 2018.
- Funds reported $1.86M of OncoSec Medical Incorporated stock for Q1 2019, down 30% quarter-over-quarter.
- 3 funds opened new OncoSec Medical Incorporated positions in Q1 2019 and 6 closed out, a net change of -3 holders.
- The largest OncoSec Medical Incorporated buyer in Q1 2019 was Intrinsic Edge Capital Management, an estimated $313K added.
- The largest OncoSec Medical Incorporated seller in Q1 2019 was Anson Funds Management, an estimated $412K sold.
Based on aggregated 13F filings for Q1 2019.